TABLE 2.
Multivariate analysis of independent predictors of AML patient prognosis
| Characteristics | Risk ratio | 95% CI | p |
|---|---|---|---|
| OS (all AML, N = 236) | |||
| WBC counts (×109/L) | 3.01 | 1.53–3.75 | 0.032 |
| Cytogenetics | 3.21 | 1.61–4.84 | 0.017 |
| Serum hsa_circ_0079480 | 3.19 | 1.59–4.62 | 0.009 |
| RFS (all AML, N = 236) | |||
| WBC counts (×109/L) | 3.15 | 1.61–4.12 | 0.022 |
| Cytogenetics | 3.62 | 1.74–5.02 | 0.012 |
| Serum hsa_circ_0079480 | 3.48 | 2.01–5.42 | 0.002 |
Abbreviations: AML, acute myeloid leukemia; OS, overall survival; RFS, relapse‐free survival; WBC, white blood cell.